HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis
Tingdong Yan(Duke-NUS Medical School), Shang Li(National University of Singapore), Aditi Qamra(National University of Singapore), Eyleen L. K. Goh(Nanyang Technological University), Wen Fong Ooi(Genome Institute of Singapore), Joscelyn Jun Quan Ng(Duke-NUS Medical School), Muhammad Khairul Ramlee(Duke-NUS Medical School), Lai-Fong Poon(Duke-NUS Medical School), James Davies(Oxford University Hospitals NHS Trust), Jess Hui Jie Ho(Duke-NUS Medical School), Alice M.S. Cheung(Duke-NUS Medical School), Luay Aswad(National University of Singapore), Frédéric Bard(National University of Singapore), Jim R. Hughes(University of Oxford), Manjie Xing(Duke-NUS Medical School), Dongliang Ma(Duke-NUS Medical School), Yan Ping Loh(National University of Singapore), Xuezhi Bi(Bioprocessing Technology Institute), Sujoy Ghosh(Pennington Biomedical Research Center), Steve Rozen(Heidelberg University), Melissa J. Fullwood(National University of Singapore), Chang Xu(National University of Singapore), Jing Wang(Shanghai Jiao Tong University), Vinay Tergaonkar(Centre for Cancer Biology), Patrick Tan(SingHealth), Gopinath M. Sundaram(Institute of Medical Biology), Prabha Sampath(Agency for Science, Technology and Research)
Cited by 52
Related Papers
Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human Genome
|Science|1998|2.2k
Myc activates telomerase
|Genes & Development|1998|659
Glycolytic Enzymes Can Modulate Cellular Life Span
|Cancer Research|2005|640
Enabling Technologies for Personalized and Precision Medicine
|Trends in biotechnology|2020|483